An International Physical Activity and Public Health Research Agenda to Inform Coronavirus Disease (COVID)-19 Policies and Practices
Summarized for GP RED by the authors James Sallis, Deepti Adlakha, Adewale Oyeyemi, and Deborah Salvo
James F. Sallis (Australian Catholic University, University of California)
D. Adlakha (Queen's University Belfast)
Adewale Oyeyemi (University of Maiduguri)
Deborah Salvo (Washington University in St. Louis)
More Info
expand_more
Abstract
What if there was a single therapy available with strong evidence that it:
a) boosts immune function and reduces inflammation (the most important physiological mechanisms determining the severity of COVID-19 infections);
b) prevents and treats most of the chronic diseases that increase risk of severe COVID-19 infections; and
c) can reduce anxiety and depression produced by the health, economic, and social isolation stress of the pandemic?
Every health care professional would demand urgent production of that agent to be prescribed to every patient infected with the coronavirus, and the world would demand that agent be given prophylactically to everyone.
No files available
Metadata only record. There are no files for this record.